Finanzen von SRx Global Inc (SRXH)SRXHSRx Global Inc

SRx Global Inc (SRXH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Health Solutions, accounting for 76.6% of total sales, equivalent to $8.77M. Another important revenue stream is Consumer Products. Understanding this composition is critical for investors evaluating how SRXH navigates market cycles within the IT Services & Consulting industry.

Evaluating the bottom line, SRx Global Inc maintains a gross margin of 26.65%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -46.17%, while the net margin is -122.05%. These profitability ratios, combined with a Return on Equity (ROE) of 4.06%, provide a clear picture of how effectively SRXH converts its operational activities into shareholder value.

In the context of the broader market, SRXH competes directly with industry leaders such as MSGM and SNAL. With a market capitalization of $16.44M, it holds a significant position in the sector. When comparing efficiency, SRXH's gross margin of 26.65% stands against MSGM's 81.59% and SNAL's 39.01%. Such benchmarking helps identify whether SRx Global Inc is trading at a premium or discount relative to its financial performance.

The financial performance of SRXH shows troubling signs, with a gross margin that has fluctuated significantly, dropping to 26.65% in Q3 2026. The net income has been consistently negative, with the latest reported net income of -4,140,000 USD in Q3 2026. The company's total equity has seen a dramatic increase to 142,989,000 USD in Q3 2026, but this is overshadowed by the recent history of losses and volatility in revenue.